Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 472241 - 472260 out of 476480 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 160MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 160MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 40MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 40MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 80MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX22) selpercatinib (adm: O) | RETEVMO 80MG TAB,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | EliLilly&Company |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RigelPharmaceuticals,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RigelPharmaceuticals,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RigelPharmaceuticals,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | RigelPharmaceuticals,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX23) pralsetinib (adm: O) | GAVRETO 100MG CAP,ORAL | 90 | Ex-factory price without vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | GenentechUSA,Inc. |
| USA | (L01EX27) capivasertib | TRUQAP 160MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX27) capivasertib | TRUQAP 200MG TAB | 4x16 | Ex-factory price without vat |
$0-0 |
$0-0 |
Breast Neoplasms | ASTRAZENECAPHARMACEUTICALSLP |
| USA | (L01EX28) repotrectinib | AUGTRYO 160MG CAP,ORAL | 14 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
| USA | (L01EX28) repotrectinib | AUGTRYO 160MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
| USA | (L01EX28) repotrectinib | AUGTYRO 40MG CAP,ORAL | 120 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
| USA | (L01EX28) repotrectinib | AUGTYRO 40MG CAP,ORAL | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
n/a | Bristol-MyersSquibbCompany |
Pages
